Skip to main content
Watch Insiders

Institutional filer profile

OrbiMed Genesis GP LLC Insider Trades

Latest reported as Corporate insider of ADARx Pharmaceuticals, Inc. (ADRX).

Purchase filings
5
Reported companies
6
Net open-market value
$46,886,944
Latest transaction
Sep 28, 2026

Affiliated corporations

Reported company relationships

ADRXLatest reported

ADARx Pharmaceuticals, Inc.

Corporate insider

ETRAPrior filing

Electra Therapeutics, Inc.

Corporate insider

BRVEPrior filing

Braveheart Bio, Inc.

Corporate insider

ELVNPrior filing

Enliven Therapeutics, Inc.

Corporate insider

QTTBPrior filing

Q32 Bio Inc.

Corporate insider

PRLDPrior filing

Prelude Therapeutics Inc

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 28, 2026ADARx Pharmaceuticals, Inc. (ADRX)Corporate insiderOpen Market Purchase950,000$17.00$16,150,000
Sep 21, 2026Electra Therapeutics, Inc. (ETRA)Corporate insiderOpen Market Purchase1,333,333$15.00$19,999,995
Aug 7, 2026Braveheart Bio, Inc. (BRVE)Corporate insiderOpen Market Purchase1,940,000$18.00$34,920,000
Jun 22, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale860,123$45.36$39,014,061
Jun 15, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale281,408$45.02$12,668,988
May 28, 2026Q32 Bio Inc. (QTTB)Corporate insiderOpen Market Purchase1,875,000$8.00$15,000,000
Apr 21, 2026Prelude Therapeutics Inc (PRLD)Corporate insiderOpen Market Purchase2,815,315$4.44$12,499,999